Cargando…

Subcutaneous Emphysema and Pneumomediastinum Following Non-invasive Ventilation in a Patient With Severe COVID-19 Disease

Subcutaneous emphysema (SE) and pneumomediastinum are rare complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While SE is often non-fatal and usually self-remitting, pneumomediastinum can be fatal with high mortality rates depending on the underlying etiology. Here, we pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tata, Ravichandra, Bingi, Thrilok Chander, Maurya, Akhilesh Kumar, Kalakuntla, Hemanth, Gangishetti, Saketh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321423/
https://www.ncbi.nlm.nih.gov/pubmed/34336526
http://dx.doi.org/10.7759/cureus.16051
_version_ 1783730847248023552
author Tata, Ravichandra
Bingi, Thrilok Chander
Maurya, Akhilesh Kumar
Kalakuntla, Hemanth
Gangishetti, Saketh
author_facet Tata, Ravichandra
Bingi, Thrilok Chander
Maurya, Akhilesh Kumar
Kalakuntla, Hemanth
Gangishetti, Saketh
author_sort Tata, Ravichandra
collection PubMed
description Subcutaneous emphysema (SE) and pneumomediastinum are rare complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While SE is often non-fatal and usually self-remitting, pneumomediastinum can be fatal with high mortality rates depending on the underlying etiology. Here, we present the case of a 39-year-old otherwise healthy male who tested positive for SARS-CoV-2. The patient was treated with non-invasive mechanical ventilation (NIMV) and developed severe SE and pneumomediastinum which resulted in a fatal outcome. Although the exact pathogenesis could not be determined, the extensive lung injury caused by SARS-CoV-2 pneumonia along with possible barotrauma secondary to NIMV could have been the culprits in this case. Early detection through careful observation of these potentially fatal complications in patients with severe coronavirus disease 2019 is crucial. Further studies determining the potential risk factors and incidence of SE and pneumomediastinum, especially in patients receiving invasive mechanical ventilation or NIMV, are needed.
format Online
Article
Text
id pubmed-8321423
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-83214232021-07-31 Subcutaneous Emphysema and Pneumomediastinum Following Non-invasive Ventilation in a Patient With Severe COVID-19 Disease Tata, Ravichandra Bingi, Thrilok Chander Maurya, Akhilesh Kumar Kalakuntla, Hemanth Gangishetti, Saketh Cureus Internal Medicine Subcutaneous emphysema (SE) and pneumomediastinum are rare complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While SE is often non-fatal and usually self-remitting, pneumomediastinum can be fatal with high mortality rates depending on the underlying etiology. Here, we present the case of a 39-year-old otherwise healthy male who tested positive for SARS-CoV-2. The patient was treated with non-invasive mechanical ventilation (NIMV) and developed severe SE and pneumomediastinum which resulted in a fatal outcome. Although the exact pathogenesis could not be determined, the extensive lung injury caused by SARS-CoV-2 pneumonia along with possible barotrauma secondary to NIMV could have been the culprits in this case. Early detection through careful observation of these potentially fatal complications in patients with severe coronavirus disease 2019 is crucial. Further studies determining the potential risk factors and incidence of SE and pneumomediastinum, especially in patients receiving invasive mechanical ventilation or NIMV, are needed. Cureus 2021-06-30 /pmc/articles/PMC8321423/ /pubmed/34336526 http://dx.doi.org/10.7759/cureus.16051 Text en Copyright © 2021, Tata et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Tata, Ravichandra
Bingi, Thrilok Chander
Maurya, Akhilesh Kumar
Kalakuntla, Hemanth
Gangishetti, Saketh
Subcutaneous Emphysema and Pneumomediastinum Following Non-invasive Ventilation in a Patient With Severe COVID-19 Disease
title Subcutaneous Emphysema and Pneumomediastinum Following Non-invasive Ventilation in a Patient With Severe COVID-19 Disease
title_full Subcutaneous Emphysema and Pneumomediastinum Following Non-invasive Ventilation in a Patient With Severe COVID-19 Disease
title_fullStr Subcutaneous Emphysema and Pneumomediastinum Following Non-invasive Ventilation in a Patient With Severe COVID-19 Disease
title_full_unstemmed Subcutaneous Emphysema and Pneumomediastinum Following Non-invasive Ventilation in a Patient With Severe COVID-19 Disease
title_short Subcutaneous Emphysema and Pneumomediastinum Following Non-invasive Ventilation in a Patient With Severe COVID-19 Disease
title_sort subcutaneous emphysema and pneumomediastinum following non-invasive ventilation in a patient with severe covid-19 disease
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321423/
https://www.ncbi.nlm.nih.gov/pubmed/34336526
http://dx.doi.org/10.7759/cureus.16051
work_keys_str_mv AT tataravichandra subcutaneousemphysemaandpneumomediastinumfollowingnoninvasiveventilationinapatientwithseverecovid19disease
AT bingithrilokchander subcutaneousemphysemaandpneumomediastinumfollowingnoninvasiveventilationinapatientwithseverecovid19disease
AT mauryaakhileshkumar subcutaneousemphysemaandpneumomediastinumfollowingnoninvasiveventilationinapatientwithseverecovid19disease
AT kalakuntlahemanth subcutaneousemphysemaandpneumomediastinumfollowingnoninvasiveventilationinapatientwithseverecovid19disease
AT gangishettisaketh subcutaneousemphysemaandpneumomediastinumfollowingnoninvasiveventilationinapatientwithseverecovid19disease